Style | Citing Format |
---|---|
MLA | Fasihiramandi M, et al.. "Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression." Biomedicine and Pharmacotherapy, vol. 89, no. , 2017, pp. 1152-1158. |
APA | Fasihiramandi M, Moridnia A, Najafi A, Sharifi M (2017). Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression. Biomedicine and Pharmacotherapy, 89(), 1152-1158. |
Chicago | Fasihiramandi M, Moridnia A, Najafi A, Sharifi M. "Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression." Biomedicine and Pharmacotherapy 89, no. (2017): 1152-1158. |
Harvard | Fasihiramandi M et al. (2017) 'Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression', Biomedicine and Pharmacotherapy, 89(), pp. 1152-1158. |
Vancouver | Fasihiramandi M, Moridnia A, Najafi A, Sharifi M. Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression. Biomedicine and Pharmacotherapy. 2017;89():1152-1158. |
BibTex | @article{ author = {Fasihiramandi M and Moridnia A and Najafi A and Sharifi M}, title = {Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression}, journal = {Biomedicine and Pharmacotherapy}, volume = {89}, number = {}, pages = {1152-1158}, year = {2017} } |
RIS | TY - JOUR AU - Fasihiramandi M AU - Moridnia A AU - Najafi A AU - Sharifi M TI - Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression JO - Biomedicine and Pharmacotherapy VL - 89 IS - SP - 1152 EP - 1158 PY - 2017 ER - |